News

GRID VIEW

No more posts



Welcome to MedEvidence: Two Docs Talk Allergies and Asthma Part 3, Prevention, The Evil Eosinophils. In this episode, Dr. Michael Koren and Dr. Sunil Joshi explore allergy shots vs. allergy drops for managing allergic rhinitis. For people with allergic rhinitis, allergy shots, and drops are two treatment options. The doctors explain the difference between the two treatments and their effectiveness in reducing allergic rhinitis symptoms. They also discuss the pros and cons of each option and how to decide which one is best for you.

This series is the perfect resource for learning about allergies and asthma. Tune in to gain a deeper understanding of these important healthcare topics.

Common medications:

  • The anti-IL5 products that affect eosinophil survival are mepolizumab (Nucala), benralizumab (Fasenra), reslizumab (Cinqair).
  • The anti-IL4/IL13 product is dupilumab (Dupixent)
  • The anti-IgE agent is omalizumab (Xolair)
  • The anti-TSLP agent is Tezepelumab. (Teszpire)

Sunil Joshi, MD, is the President and Managing Partner of Family Allergy Asthma Consultants in Jacksonville, Florida. The Past-President of the Duval County Medical Society (the largest and oldest Medical Society in Florida) and a graduate for the University of Florida College of Medicine. Dr. Joshi received his Allergy/Immunology fellowship training at the University of Rochester in New York.  He truly enjoys treating patients with allergic disorders and believes that education about these disease processes can bring better care to the public.

Michael J. Koren, MD, is a practicing cardiologist and Chief Executive Officer at Jacksonville Center for Clinical Research, which conducts clinical trials at 7 locations in Florida. He received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine and fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.

He is a fellow of the American College of Cardiology, fellow and two-time president of the Academy of Physicians in Clinical Research, and the regional chapter of the American Heart Association.


Prefer to listen to the podcast without video? You can do that below!








Welcome to MedEvidence: Two Docs Talk Allergies and Asthma Part 2, Prevention, Testing, and Treatment.  In this episode, Dr. Michael Koren and Dr. Sunil Joshi explore the importance of prevention before treatment and the different testing and treatment options available for pollen allergies. They also cover clinical treatments, such as immunotherapy, and how they can help manage symptoms.

This series is the perfect resource for learning about allergies and asthma. Tune in to gain a deeper understanding of these important healthcare topics.

Common medications:

  • The anti-IL5 products that affect eosinophil survival are mepolizumab (Nucala), benralizumab (Fasenra), reslizumab (Cinqair).
  • The anti-IL4/IL13 product is dupilumab (Dupixent)
  • The anti-IgE agent is omalizumab (Xolair)
  • The anti-TSLP agent is Tezepelumab. (Teszpire)

Sunil Joshi, MD, is the President and Managing Partner of Family Allergy Asthma Consultants in Jacksonville, Florida. The Past-President of the Duval County Medical Society (the largest and oldest Medical Society in Florida) and a graduate for the University of Florida College of Medicine. Dr. Joshi received his Allergy/Immunology fellowship training at the University of Rochester in New York.  He truly enjoys treating patients with allergic disorders and believes that education about these disease processes can bring better care to the public.

Michael J. Koren, MD, is a practicing cardiologist and Chief Executive Officer at Jacksonville Center for Clinical Research, which conducts clinical trials at 7 locations in Florida. He received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine and fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.

He is a fellow of the American College of Cardiology, fellow and two-time president of the Academy of Physicians in Clinical Research, and the regional chapter of the American Heart Association.


Prefer to listen to the podcast without video? You can do that below!








Welcome to MedEvidence: Two Docs Talk Allergies and Asthma. In this part 4 series, Dr. Michael Koren and Dr. Sunil Joshi bring expert insights and valuable knowledge on allergies and asthma. Today’s Part 1- Pollen Season and Symptoms Associated with Pollen Allergies: As pollen season approaches, many people experience a range of symptoms associated with pollen allergies. The doctors discuss the common symptoms of pollen allergies, such as itchy eyes, runny nose, and congestion. They also cover the types of pollen that cause allergies and ways to avoid exposure.

This series is the perfect resource for learning about allergies and asthma. Tune in to gain a deeper understanding of these important healthcare topics.

Common medications:

  • The anti-IL5 products that affect eosinophil survival are mepolizumab (Nucala), benralizumab (Fasenra), reslizumab (Cinqair).
  • The anti-IL4/IL13 product is dupilumab (Dupixent)
  • The anti-IgE agent is omalizumab (Xolair)
  • The anti-TSLP agent is Tezepelumab. (Teszpire)

Sunil Joshi, MD, is the President and Managing Partner of Family Allergy Asthma Consultants in Jacksonville, Florida. The Past-President of the Duval County Medical Society (the largest and oldest Medical Society in Florida) and a graduate for the University of Florida College of Medicine. Dr. Joshi received his Allergy/Immunology fellowship training at the University of Rochester in New York.  He truly enjoys treating patients with allergic disorders and believes that education about these disease processes can bring better care to the public.

Michael J. Koren, MD, is a practicing cardiologist and Chief Executive Officer at Jacksonville Center for Clinical Research, which conducts clinical trials at 7 locations in Florida. He received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine and fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.

He is a fellow of the American College of Cardiology, fellow and two-time president of the Academy of Physicians in Clinical Research, and the regional chapter of the American Heart Association.


Prefer to listen to the podcast without video? You can do that below!








Welcome to MedEvidence: Two Docs Talk Hospice and Palliative Care Part 4. In this final episode, Dr. Michael Koren and Dr. Alpa Patel discuss palliative care vs. hospice and possible ways to set up clinical research options.

Whether you are a patient, caregiver, or healthcare professional, this series is the perfect resource for learning about hospice and palliative care. Tune in to gain a deeper understanding of these important healthcare topics and discover how they can help improve the lives of patients and their families.

Alpa Patel, MD, is an internal medicine expert in preventive care and patient-centered services at Millennium Physicians Group and has been practicing clinical research for 16 years at ENCORE Research Group.  She received her Doctor of Medicine from, the University of Florida College of Medicine, Gainesville, FL. with her residency at the University of Florida Health Jacksonville Department of Internal Medicine, Jacksonville, FL.

Michael J. Koren, MD, is a practicing cardiologist and Chief Executive Officer at Jacksonville Center for Clinical Research, which conducts clinical trials at 7 locations in Florida. He received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine and fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.

He is a fellow of the American College of Cardiology, fellow and two-time president of the Academy of Physicians in Clinical Research, and the regional chapter of the American Heart Association.


Prefer to listen to the podcast without video? You can do that below!








Welcome to MedEvidence: Two Docs Talk Hospice and Palliative Care Part 3. In this episode, Dr. Alpa Patel shares how her family looked at palliative care from the standpoint of the family and what dynamics came into play to help them make their decision.

Whether you are a patient, caregiver, or healthcare professional, this series is the perfect resource for learning about hospice and palliative care. Tune in to gain a deeper understanding of these important healthcare topics and discover how they can help improve the lives of patients and their families.

Alpa Patel, MD, is an internal medicine expert in preventive care and patient-centered services at Millennium Physicians Group and has been practicing clinical research for 16 years at ENCORE Research Group.  She received her Doctor of Medicine from, the University of Florida College of Medicine, Gainesville, FL. with her residency at the University of Florida Health Jacksonville Department of Internal Medicine, Jacksonville, FL.

Michael J. Koren, MD, is a practicing cardiologist and Chief Executive Officer at Jacksonville Center for Clinical Research, which conducts clinical trials at 7 locations in Florida. He received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine and fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.

He is a fellow of the American College of Cardiology, fellow and two-time president of the Academy of Physicians in Clinical Research, and the regional chapter of the American Heart Association.


Prefer to listen to the podcast without video? You can do that below!








In this episode, Dr. Michael Koren and Dr. Alpa Patel discuss palliative care from the standpoint of patients with severe chronic diseases.

Whether you are a patient, caregiver, or healthcare professional, this series is the perfect resource for learning about hospice and palliative care. Tune in to gain a deeper understanding of these important healthcare topics and to discover how they can help improve the lives of patients and their families.

Alpa Patel, MD, is an internal medicine expert in preventive care and patient-centered services at Millennium Physicians Group and has been practicing clinical research for 16 years at ENCORE Research Group.  She received her Doctor of Medicine from, the University of Florida College of Medicine, Gainesville, FL. with her residency at the University of Florida Health Jacksonville Department of Internal Medicine, Jacksonville, FL.

Michael J. Koren, MD, is a practicing cardiologist and Chief Executive Officer at Jacksonville Center for Clinical Research, which conducts clinical trials at 7 locations in Florida. He received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine and fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.

He is a fellow of the American College of Cardiology, fellow and two-time president of the Academy of Physicians in Clinical Research, and the regional chapter of the American Heart Association.


Prefer to listen to the podcast without video? You can do that below!








Welcome to MedEvidence: Two Docs Talk Hospice and Palliative Care. In this 4 part podcast series, Dr. Michael Koren and Dr. Alpa Patel bring you personal stories, expert insights and valuable knowledge on the importance of Hospice and Palliative Care for patients suffering from severe chronic diseases. Part 1 focuses on cure vs. comfort.

Whether you are a patient, caregiver, or healthcare professional, this series is the perfect resource for learning about hospice and palliative care. Tune in to gain a deeper understanding of these important healthcare topics and to discover how they can help improve the lives of patients and their families.

Alpa Patel, MD, is an internal medicine expert in preventive care and patient-centered services at Millennium Physicians Group and has been practicing clinical research for 16 years at ENCORE Research Group.  She received her Doctor of Medicine from, the University of Florida College of Medicine, Gainesville, FL. with her residency at the University of Florida Health Jacksonville Department of Internal Medicine, Jacksonville, FL.

Michael J. Koren, MD, is a practicing cardiologist and Chief Executive Officer at Jacksonville Center for Clinical Research, which conducts clinical trials at 7 locations in Florida. He received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine and fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.

He is a fellow of the American College of Cardiology, fellow and two-time president of the Academy of Physicians in Clinical Research, and the regional chapter of the American Heart Association.


Prefer to listen to the podcast without video? You can do that below!








In this episode of MedEvidence, we delve into the critical issue of healthcare burnout during the pandemic. Dr. Michael Koren and Dr. Lisa Kirvin-Dawes, bring their expertise and insights as healthcare professionals to discuss the challenges and impacts of the pandemic on the mental and emotional well-being of healthcare workers. They share their experiences and offer practical advice for navigating burnout, managing stress, and finding support. Join us for a thought-provoking conversation on an important issue affecting the healthcare industry today.

Lisa Kirven-Dawes, MD, is a practicing physician in Jamacia focusing on infectious control, diseases, and care & the former Chair of Medicine and graduate of Harvard Medical School. Michael J. Koren, MD, is a practicing cardiologist and Chief Executive Officer at Jacksonville Center for Clinical Research, which conducts clinical trials at 7 locations in Florida. He received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine and fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.

He is a fellow of the American College of Cardiology, fellow and two-time president of the Academy of Physicians in Clinical Research, and the regional chapter of the American Heart Association.

Dr. Koren has served as an Investigator in over 2,000 trials and as the international lead investigator for many multi-centered trials, including ALLIANCE, ROLE, TREAT to TARGET, OSLER, and MENDEL studies. He has written and co-authored over 100 peer-reviewed articles and been published in the most prestigious medical journals. Dr. Koren has also designed a research training course for physicians, now in its 20th year.


Prefer to listen to the podcast without video? You can do that below!







MedEvidence! Radio is a monthly live broadcast from WSOS 103.9 FM / 1170 AM with Kevin Geddings and Dr. Michael Koren. This month’s MedEvidence Radio discusses the Silent Killer, Lipoprotein(a), Diabetes, and Clinical Research Technologies.

We will dive into the following:
🩺 Clinical Research
💙 Lipoprotein(a)
🍬 Diabetes
❤️ Cardiovascular Health
🔬 Clinical Research Trials

Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals.  Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.  On a personal note, Dr. Koren has a lifelong interest in history, technology, Public Health, and music. He has written two musical plays.


Listen to the full episode here:





Dr.’s Michael Koren and Dennis Leahy wrap up the MedEvidence Lipoprotein A series by exploring Lp(a) clinical trial treatments. Dr. Leahy shares his personal clinical research experience and platform for encouraging everyone to have their LP(a) blood work drawn. Tune in to learn more about this lesser-known condition, possible treatment options, and the future of Lp(a).

Dr. Dennis Leahy is a retired interventional cardiologist living in San Diego. He received his education from Princeton University and Columbia University and his residency at the University of California. In addition to enjoying the opportunity to surf and golf, he has maintained a personal and professional interest in Lipoprotein A research and treatment.

Michael J. Koren, MD, is a practicing cardiologist and Chief Executive Officer at Jacksonville Center for Clinical Research, which conducts clinical trials at 7 locations in Florida. He received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine and fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.

He is a fellow of the American College of Cardiology, fellow and two-time president of the Academy of Physicians in Clinical Research, and the regional chapter of the American Heart Association.

Dr. Koren has served as an Investigator in over 2,000 trials and as the international lead investigator for many multi-centered trials, including ALLIANCE, ROLE, TREAT to TARGET, OSLER, and MENDEL studies. He has written and co-authored over 100 peer-reviewed articles and been published in the most prestigious medical journals. Dr. Koren has also designed a research training course for physicians, now in its 20th year.


Prefer to listen to the podcast without video? You can do that below!








Continuing with Part 3 of Dr.’s Michael Koren and Dennis Leahy discussion on MedEvidence exploring Lipoprotein A treatments. Dr. Leahy shares his personal experience with Lp(a), and the duo delves into cutting-edge treatments and research. Tune in to learn more about this lesser known condition and possible treatment options.

Dr. Dennis Leahy is a retired interventional cardiologist living in San Diego. He received his education from Princeton University and Columbia University and his residency at the University of California. In addition to enjoying the opportunity to surf and golf, he has maintained a personal and professional interest in Lipoprotein A research and treatment.

Michael J. Koren, MD, is a practicing cardiologist and Chief Executive Officer at Jacksonville Center for Clinical Research, which conducts clinical trials at 7 locations in Florida. He received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine and fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.

He is a fellow of the American College of Cardiology, fellow and two-time president of the Academy of Physicians in Clinical Research, and the regional chapter of the American Heart Association.

Dr. Koren has served as an Investigator in over 2,000 trials and as the international lead investigator for many multi-centered trials, including ALLIANCE, ROLE, TREAT to TARGET, OSLER, and MENDEL studies. He has written and co-authored over 100 peer-reviewed articles and been published in the most prestigious medical journals. Dr. Koren has also designed a research training course for physicians, now in its 20th year.


Prefer to listen to the podcast without video? You can do that below!








Dr.’s Michael Koren and Dennis Leahy, cardiovascular specialists, continue with part 2 in a 4 part series of MedEvidence exploring Lipoprotein A, also know as Lp(a). Dr. Leahy shares his personal experience with Lp(a), and the duo delves into cutting-edge strategies for managing this risk factor for cardiovascular disease. So, tune in to learn more about this lesser known condition and possible treatment options.

Dr. Dennis Leahy is a retired interventional cardiologist living in San Diego. He received his education from Princeton University and Columbia University and his residency at the University of California. In addition to enjoying the opportunity to surf and golf, he has maintained a personal and professional interest in Lipoprotein A research and treatment.

Michael J. Koren, MD, is a practicing cardiologist and Chief Executive Officer at Jacksonville Center for Clinical Research, which conducts clinical trials at 7 locations in Florida. He received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine and fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.

He is a fellow of the American College of Cardiology, fellow and two-time president of the Academy of Physicians in Clinical Research, and the regional chapter of the American Heart Association.

Dr. Koren has served as an Investigator in over 2,000 trials and as the international lead investigator for many multi-centered trials, including ALLIANCE, ROLE, TREAT to TARGET, OSLER, and MENDEL studies. He has written and co-authored over 100 peer-reviewed articles and been published in the most prestigious medical journals. Dr. Koren has also designed a research training course for physicians, now in its 20th year.


Prefer to listen to the podcast without video? You can do that below!








Join Dr.’s Michael Koren and Dennis Leahy, cardiovascular specialists, in a 4 part series of MedEvidence exploring Lipoprotein a, also known as Lp(a). Dr. Leahy shares his personal experience with LP(a), and the duo delves into cutting-edge strategies for managing this risk factor for cardiovascular disease. So, tune in to learn more about this lesser-known condition and possible treatment options.

Dr. Dennis Leahy is a retired interventional cardiologist living in San Diego. He received his education from Princeton University and Columbia University and his residency at the University of California. In addition to enjoying the opportunity to surf and golf, he has maintained a personal and professional interest in Lipoprotein A research and treatment.

Michael J. Koren, MD, is a practicing cardiologist and Chief Executive Officer at Jacksonville Center for Clinical Research, which conducts clinical trials at 7 locations in Florida. He received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine and fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.

He is a fellow of the American College of Cardiology, fellow and two-time president of the Academy of Physicians in Clinical Research, and the regional chapter of the American Heart Association.

Dr. Koren has served as an Investigator in over 2,000 trials and as the international lead investigator for many multi-centered trials, including ALLIANCE, ROLE, TREAT to TARGET, OSLER, and MENDEL studies. He has written and co-authored over 100 peer-reviewed articles and been published in the most prestigious medical journals. Dr. Koren has also designed a research training course for physicians, now in its 20th year.


Prefer to listen to the podcast without video? You can do that below!







In honor of American Heart Month,  Dr. Michael Koren was on the SCRS Talks podcast to share his top tips for heart health. Dr. Koren also explores how cardiovascular research and treatment have progressed over the past several years and some exciting new learnings for this vital therapeutic area.

Michael J. Koren, MD, is a practicing cardiologist and Chief Executive Officer at Jacksonville Center for Clinical Research, which conducts clinical trials at 7 locations in Florida. He received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine and fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.

He is a fellow of the American College of Cardiology, fellow and two-time president of the Academy of Physicians in Clinical Research, and the regional chapter of the American Heart Association.

Dr. Koren has served as an Investigator in over 2,000 trials and as the international lead investigator for many multi-centered trials, including ALLIANCE, ROLE, TREAT to TARGET, OSLER, and MENDEL studies. He has written and co-authored over 100 peer-reviewed articles and been published in the most prestigious medical journals. Dr. Koren has also designed a research training course for physicians, now in its 20th year.

On a personal note, Dr. Koren developed a lifelong interest in technology and Public Health during his time at The Massachusetts Institute of Technology and The Harvard School of Public Health. He also loves music. He has written two musical plays.






Join us on the MedEvidence podcast as we reunite Staten Island middle school friends Dr. Michael Koren and Mick LaSalle. As experts in their respective fields, their discussion explores the intersection of clinical research, film criticism, and humor. Don’t miss this unique and entertaining episode of the MedEvidence podcast!

Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Mick LaSalle, film critic for The San Francisco Chronicle and former on-air film critic for the ABC-TV affiliate in San Francisco, KGO. He is the author of Complicated Women: Sex and Power in Pre-Code Hollywood (2000), Dangerous Men: Pre-Code Hollywood and the Birth of the Modern Man (2002); The Beauty of the Real: What Hollywood Can Learn from Contemporary French Actresses (2012); and Dream State: California in the Movies (2021).  With Leba Hertz, he hosted the Mick LaSalle podcast between 2005 and 2010. He wrote and co-produced the Complicated Women documentary for Turner Classic Movies, which Jane Fonda narrated. He has also written introductions to several books, including The Enduring Star, Peter Cowie’s biography of Joan Crawford (Rizzoli, 2009). He met Dr. Michael Koren in Middle School during the 1970s.


Prefer to listen to the podcast without video? You can do that below!








Dr. Michael Koren sits down with his middle school buddy, Mick LaSalle, a well-known film critic, to discuss changes in the direction of medicine & media. Their “Staten Island humor” is evident as they talk about how the media markets medicine from aspirin to covid, what the media says vs. what the medical data proves.

Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Mick LaSalle, film critic for The San Francisco Chronicle and former on-air film critic for the ABC-TV affiliate in San Francisco, KGO. He is the author of Complicated Women: Sex and Power in Pre-Code Hollywood (2000), Dangerous Men: Pre-Code Hollywood and the Birth of the Modern Man (2002); The Beauty of the Real: What Hollywood Can Learn from Contemporary French Actresses (2012); and Dream State: California in the Movies (2021).  With Leba Hertz, he hosted the Mick LaSalle podcast between 2005 and 2010. He wrote and co-produced the Complicated Women documentary for Turner Classic Movies, which Jane Fonda narrated. He has also written introductions to several books, including The Enduring Star, Peter Cowie’s biography of Joan Crawford (Rizzoli, 2009). He met Dr. Michael Koren in Middle School during the 1970s.


Prefer to listen to the podcast without video? You can do that below!








Brad Hightower, the founder of Hightower Clinical, clinical research professional, and host of the Note to File podcast, sits down with Dr. Michael Koren to discuss clinical research as a care option, decentralized clinical trials, and clinical research technology and data collection using EMRs and CTMS such as Clinasyst.

Michael J. Koren, MD, is a practicing cardiologist and Chief Executive Officer at Jacksonville Center for Clinical Research, which conducts clinical trials at 7 locations in Florida. He received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine and fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.

He is a fellow of the American College of Cardiology, fellow and two-time president of the Academy of Physicians in Clinical Research, and the regional chapter of the American Heart Association.

Dr. Koren has served as an Investigator in over 2,000 trials and as the international lead investigator for many multi-centered trials, including ALLIANCE, ROLE, TREAT to TARGET, OSLER, and MENDEL studies. He has written and co-authored over 100 peer-reviewed articles and been published in the most prestigious medical journals. Dr. Koren has also designed a research training course for physicians, now in its 20th year.

On a personal note, Dr. Koren developed a lifelong interest in technology and Public Health during his time at The Massachusetts Institute of Technology and The Harvard School of Public Health. He also loves music. He has written two musical plays.

Brad Hightower, founder of Hightower Clinical, clinical research professional, and host of the Note to File podcast. Brad lives, works, and podcasts from Oklahoma City, OK.  He has worked at the site level in clinical research for ten years and is the former Executive Director of the Oklahoma Heart Hospital Research Foundation.  Brad has since started his own integrated site network, Hightower Clinical.
To learn more about Hightower Clinical, please visit hightowerclinical.com.
To connect with Brad, please reach out on LinkedIn.




MedEvidence! Radio is a monthly live broadcast from WSOS 103.9 FM / 1170 AM with Kevin Geddings and Dr. Michael Koren. This month’s MedEvidence Radio discusses Damar Hamlin’s cardiac event during a football game on January 2, 2023.

We will dive into the following:
🩺 Commotio cordis
🩺 Hypertrophic Cardiomyopathy
🩺 Atrial Fibrillation
❤️ Cardiovascular Health
🔬 Clinical Research Trials

Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals.  Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.  On a personal note, Dr. Koren has a lifelong interest in history, technology, Public Health, and music. He has written two musical plays.


Listen to the full episode here:





The Next Generation of Clinical Researchers series concludes with a discussion of research outreach, research ambassadors, and the value of educating the community about clinical research to help advance medicine and healthcare for all.

Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Adrian Rowda, a second-generation clinical researcher, graduated from Jacksonville University in 2008 with a BSN. Followed by working as a nurse in Mayo Clinic’s Surgical Intensive Care Unit and ED for 6 years.  In 2014 she graduated from Jacksonville University with her MSN as a Family Nurse Practitioner and began working at UF Health in their Trauma/Surgical Intensive Care Unit for 3 years.  Since 2017 she has been with Baptist Medical Center in their Neuro Intensive Care Unit.


Prefer to listen to the podcast without video? You can do that below!







Episode three in the MedEvidence series, The Next Generation of Clinical Researchers discusses patients’ value propositions for the next generation as spoken by a second-generation researcher.

Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Adrian Rowda, a second-generation clinical researcher, graduated from Jacksonville University in 2008 with a BSN. Followed by working as a nurse in Mayo Clinic’s Surgical Intensive Care Unit and ED for 6 years.  In 2014 she graduated from Jacksonville University with her MSN as a Family Nurse Practitioner and began working at UF Health in their Trauma/Surgical Intensive Care Unit for 3 years.  Since 2017 she has been with Baptist Medical Center in their Neuro Intensive Care Unit.


Prefer to listen to the podcast without video? You can do that below!







What characteristics, quality & attributes are needed for the Next Generation of Clinical Researchers? Listen in as the current, future & second-generation of researchers discuss this topic and share personal stories.

Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Adrian Rowda, a second-generation clinical researcher, graduated from Jacksonville University in 2008 with a BSN. Followed by working as a nurse in Mayo Clinic’s Surgical Intensive Care Unit and ED for 6 years.  In 2014 she graduated from Jacksonville University with her MSN as a Family Nurse Practitioner and began working at UF Health in their Trauma/Surgical Intensive Care Unit for 3 years.  Since 2017 she has been with Baptist Medical Center in their Neuro Intensive Care Unit.


Prefer to listen to the podcast without video? You can do that below!







Listen in on the new MedEvidence series, The Next Generation of Clinical Researchers, to learn how research transfers knowledge from generation to generation as spoken by a second-generation researcher.

Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Adrian Rowda, a second-generation clinical researcher, graduated from Jacksonville University in 2008 with a BSN. Followed by working as a nurse in Mayo Clinic’s Surgical Intensive Care Unit and ED for 6 years.  In 2014 she graduated from Jacksonville University with her MSN as a Family Nurse Practitioner and began working at UF Health in their Trauma/Surgical Intensive Care Unit for 3 years.  Since 2017 she has been with Baptist Medical Center in their Neuro Intensive Care Unit.


Prefer to listen to the podcast without video? You can do that below!






MedEvidence! Radio is a monthly live broadcast from WSOS 103.9 FM / 1170 AM with Kevin Geddings and Dr. Michael Koren from St. Augustine, Florida. This month’s MedEvidence Radio discusses the diabetic epidemic in the US.

We will dive into:
💉GLP-1 Drug Class
💉SGLT2i Drug Class
💉Newer Class of Diabetic Drugs
❤️Cardiovascular Safety
🔬 Past and New Clinical Research Trials

Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals.  Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.  On a personal note, Dr. Koren has a lifelong interest in history, technology, Public Health, and music. He has written two musical plays.


Listen to the full episode here:





The MedEvidence Diabetes series concludes with managing individual patients’ diabetic needs with anecdotes and stories by Dr. Koren and Sharon Smith.

Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Sharon Smith, RN, CDCES, is the VP of Recruitment at ENCORE Research Group and a Diabetic Educational Nurse with a passion for educating patients as well as staff on healthy lifestyle options without giving up on special treats.


Prefer to listen to the podcast without video? You can do that below!







In part 3 of the MedEvidence Diabetes series Dr. Koren and Sharon Smith discuss choosing drug classes for diabetes, weight loss and cardiovascular health.

💉GLP-1 Drug Class
💉SGLT2i Drug Class
🔬 Past and New Clinical Research Trials

Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Sharon Smith, RN, CDCES, is the VP of Recruitment at ENCORE Research Group and a Diabetic Educational Nurse with a passion for educating patients as well as staff on healthy lifestyle options without giving up on special treats.


Prefer to listen to the podcast without video? You can do that below!







What does a diabetic educational nurse want you to know about blood sugars, and what is a cardiovascular doctor doing in the diabetes space? Let’s find out! In part 2 of the MedEvidence diabetes series, Dr. Michael Koren and Sharon Smith will discuss:

🩺  4 Main Components of Type 2 Diabetes Care
💉  Newer Classes of Diabetic Drugs
❤️  Cardiovascular Safety
🔬  New and Past Clinical Research Trials

Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Sharon Smith, RN, CDCES, is the VP of Recruitment at ENCORE Research Group and a Diabetic Educational Nurse with a passion for educating patients as well as staff on healthy lifestyle options without giving up on special treats.


Prefer to listen to the podcast without video? You can do that below!







In honor of American Diabetes Month, we are releasing the MedEvidence! Diabetes series. In this episode, Dr. Michael Koren and Diabetic Nurse Educator, Sharon Smith explain the basics of diabetes and the history of diabetic drugs.

In this issue, you will learn:
🩺Type 1 vs Type 2

💉History of Diabetic Drugs

❤️Cardiovascular Safety

Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.


Prefer to listen to the podcast without video? You can do that below!






MedEvidence Radio is a monthly live broadcast from WSOS 103.9 FM / 1170 AM with Kevin Geddings and Dr. Michael Koren from St. Augustine, Florida. This month’s MedEvidence Radio discusses all the various viruses coming our way this season.

We will dive into:

  • RSV – Respiratory Syncytial Virus
  • COVID
  • Flu
  • Developing a virus strategy plan
  • Vaccine effects
  • Antibody levels

Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.


Prefer to listen to the podcast without video? You can do that below!





MedEvidence! Radio is a monthly live broadcast from WSOS 103.9 FM / 1170 AM with Kevin Geddings and Dr. Michael Koren from St. Augustine, Florida. This month, Dr. Erich Schramm joins the conversation in discussing whether patients benefit from clinical research and, if so how?

Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Dr. Erich Schramm, MD, is a board-certified family physician in Ponte Vedra, Florida, with 22 years of experience. He is currently a principal investigator with ENCORE Research Group.


Prefer to listen to the podcast without video? You can do that below!





This week’s MedEvidence podcast concludes with episode 4 of our series about MedEvidence. Dr. Koren explains the passion, goals, and need for MedEvidence a trusted resource at a time when the world is filled with misinformation.  Meet the team behind MedEvidence, where we learn how medical truths are found. What hypothesis testing is, the history of finding truth through research, and Dr. Koren’s founding of  Jacksonville Center for Clinical Research.

Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.




This week’s MedEvidence podcast continues with episode 3, where we learn how medical truths are found. What hypothesis testing is, the history of finding truth through research, and Dr. Koren’s founding of  Jacksonville Center for Clinical Research.

Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.




This week’s MedEvidence podcast continues with episode 2, where we learn a little personal history about our founder, Dr. Michael Koren. From the gas attendant’s son to Harvard Medical School to ENCORE Research Group, who is the man behind the white coat?

Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.




This MedEvidence podcast is a four-part series. MedEvidence, What Is It and Why Does the World Need It?  Michelle McCormick asked Dr. Michael Koren why he created MedEvidence and why it’s so important in a world filled with misinformation.

You will learn how MedEvidence will:

  • MedEvidence is a truth-based interface to help people make medical decisions
  • How MedEvidence will help you understand confusing claims in medical news
  • Help you decipher medical scenarios that are difficult to sort through
  • Learn more about Clinical Research

Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.




This week’s MedEvidence podcast is on Medical Marijuana. Meet Dr. Charlie Booras, former Principal Investigator at Jacksonville Center of Clinical Research, and Baptist Primary Care physician who grew his practice into Booras MD as a tribute to his father after treating his ALS with medical cannabis as a medication. Dr. Michael Koren and Dr. Booras dive into the scientific basis for the efficacy of medical cannabis.

You will learn:

        • Florida Medical Marijuana Law and Process
        • THC vs. CBD
        • Health Benefits for Medical Marijuana
        • History of Marijuana
        • Learn more about Clinical Research
        • Learn more about BoorasMD

Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.


Prefer to listen to the podcast without video? You can do that below!






This week’s MedEvidence podcast is the second episode in a two-part series on Liquid Biopsy.

In this 24-minute episode Doctors, Michael Koren and Bharat Misra discuss liquid biopsy usage now & in the future of medical evaluations.

You will learn:

Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Dr. Bharat Misra is the Medical Director of ENCORE Borland Groover Clinical Research and has been a Principal Investigator of numerous clinical trials. He also serves on the board of directors at Memorial Hospital and Jacksonville Center for Clinical Research in Jacksonville, Florida. He completed his residency in internal medicine and fellowship in gastroenterology at the Nassau University Medical Center, State University of New York, and his Bachelor of Medicine and Bachelor of Surgery from Gandhi Medical College in India.


Prefer to listen to the podcast without video? You can do that below!





This week’s MedEvidence podcast is a two-part series on Liquid Biopsy: What is it & Do I Need One?

In this 22-minute episode Doctors, Michael Koren and Bharat Misra explain liquid biopsies and conditions that are subject to evaluations with liquid biopsies.

You will learn

Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Dr. Bharat Misra is the Medical Director of ENCORE Borland Groover Clinical Research and has been a Principal Investigator of numerous clinical trials. He also serves on the board of directors at Memorial Hospital and Jacksonville Center for Clinical Research in Jacksonville, Florida. He completed his residency in internal medicine and fellowship in gastroenterology at the Nassau University Medical Center, State University of New York, and his Bachelor of Medicine and Bachelor of Surgery from Gandhi Medical College in India.


Prefer to listen to the podcast without video? You can do that below!





“What’s New with the Flu?”  Dr. Michael Koren, Dr. Victoria Helow, and Michelle McCormick discuss Flu and COVID.

Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Dr. Victoria Helow, is a well-respected pediatrician, clinical research investigator at ENCORE Research Group, and practicing emergency room physician.


Prefer to listen to the podcast without video? You can do that below!





Wrapping up this month’s MedEvidence! podcast series on “What to do after a Heart Attack or Stroke?”  Doctors, Michael Koren and Albert Lopez, DO discuss treatments, medications, and clinical research you need to know as a post-heart event patient.

You will learn:

  • Treatment therapies to use after a heart attack or stroke
  • What is Lp(a)
  • Male vs Female Symptoms
  • Cardiovascular Disease Research

Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Dr. Albert Lopez, DO practices Internal Medicine with Millennium Physician Group in Jacksonville, Florida. He is also a Principal Investigator with ENCORE Research Group specializing in lipid clinical trials. Dr. Lopez, DO completed his residency at the University of Pennsylvania and his Doctor of Osteopathic Medicine at Nova Southeastern University in Miami, Florida. He is known as one of the earliest evidence-based physicians in Jacksonville utilizing nutrition and lifestyle for disease prevention.
I believe in “N” of one” because “N of one” is about the patient. If it is not about the patient, then it is about nothing. – Dr. Albert Lopez, DO


Prefer to listen to the podcast without video? You can do that below!





This month’s MedEvidence! podcast is a three-part series on “What to do after a Heart Attack or Stroke?” In the first MedEvidence segment we established that people who have had either a heart attack or stroke have a high risk for a repeat procedure or event. We also discussed knowing who’s on your Heart Health Team, PCP, specialist, and family. What’s abnormal, normal, and what to do when symptoms last greater than 20 minutes? In this 15-minute episode, Doctors, Michael Koren and Albert Lopez DO discuss the Risk Factors You Need to know for your heart health.

You will learn:

      • What modifiable risk factors are
      • What non-modifiable risk factors are
      •  What you can do to help your risk factors
      • How clinical trials and research find other drug benefits
      • How to be involved in a clinical trial

Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Dr. Albert Lopez, DO practices Internal Medicine with Millennium Physician Group in Jacksonville, Florida. He is also a Principal Investigator with ENCORE Research Group specializing in lipid clinical trials. Dr. Lopez, DO completed his residency at the University of Pennsylvania and his Doctor of Osteopathic Medicine at Nova Southeastern University in Miami, Florida. He is known as one of the earliest evidence-based physicians in Jacksonville utilizing nutrition and lifestyle for disease prevention.
I believe in “N” of one” because “N of one” is about the patient. If it is not about the patient, then it is about nothing. – Dr. Albert Lopez, DO


Prefer to listen to the podcast without video? You can do that below!





This MedEvidence! podcast is a three-part series on “What to do after a Heart Attack or Stroke?” In this episode, Doctors, Michael Koren and Albert Lopez, DO help you identify your heart health team.

You will learn:

    • Who do I call if I think I’m having a heart attack?
    • What are my risks for another event?
    • How can my family help?
    • How to find a clinical trial

Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Dr. Albert Lopez, DO practices Internal Medicine with Millennium Physician Group in Jacksonville, Florida. He is also a Principal Investigator with ENCORE Research Group specializing in lipid clinical trials. Dr. Lopez, DO completed his residency at the University of Pennsylvania and his Doctor of Osteopathic Medicine at Nova Southeastern University in Miami, Florida. He is known as one of the earliest evidence-based physicians in Jacksonville utilizing nutrition and lifestyle for disease prevention.
I believe in “N” of one” because “N of one” is about the patient. If it is not about the patient, then it is about nothing. – Dr. Albert Lopez, DO


Prefer to listen to the podcast without video? You can do that below!





On this month’s MedEvidence radio episode, Doctors Michael Koren, MD, Matthew Todd Braddock, DO, Jackson Downey, MD, Albert Lopez, DO and WSOS Radio Host Kevin Geddings discuss NASH, Fatty Liver, and Fibroscans.

This month’s MedEvidence! Radio will answer:

  • What is NASH?
  • What are the stages of NASH?
  • How do you treat NASH?
  • Is NASH reversible?
  • Is NASH related to cholesterol problems?

MedEvidence! Radio is a monthly live broadcast from WSOS 103.9 FM / 1170 AM with Kevin Geddings from St. Augustine, Florida. Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals.  Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.  On a personal note, Dr. Koren has a lifelong interest in history, technology, Public Health, and music. He has written two musical plays.


Listen to the full episode here:




In this final 30-minute episode Doctors, Michael Koren and Bharat Misra dive into new treatments in clinical trials for Fatty Liver Disease and NASH.

You will learn

Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Dr. Bharat Misra is the Medical Director of ENCORE Borland Groover Clinical Research and has been a Principal Investigator of numerous clinical trials. He also serves on the board of directors at Memorial Hospital and Jacksonville Center for Clinical Research in Jacksonville, Florida. He completed his residency in internal medicine and fellowship in gastroenterology at the Nassau University Medical Center, State University of New York, and his Bachelor of Medicine and Bachelor of Surgery from Gandhi Medical College in India.


Prefer to listen to the podcast without video? You can do that below!





This month’s MedEvidence! Hour is a three-part series on You Cannot Live without Your Liver.   In this 14-minute Part 2 episode Doctors, Michael Koren and Bharat Misra answer your questions on Fibroscans.

  • Who should receive a Fibroscan
  • How often should I get a Fibroscan
  • Should I ask my primary doctor for a Fibroscan
  • Liver Biopsy vs. Fibroscan
  • Insurance and Fibroscan
  • What should I do after my Fibroscan
  • How to find a free Fibroscan

Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Dr. Bharat Misra is the Medical Director of ENCORE Borland Groover Clinical Research and has been a Principal Investigator of numerous clinical trials. He also serves on the board of directors at Memorial Hospital and Jacksonville Center for Clinical Research in Jacksonville, Florida. He completed his residency in internal medicine and fellowship in gastroenterology at the Nassau University Medical Center, State University of New York, and his Bachelor of Medicine and Bachelor of Surgery from Gandhi Medical College in India.


Prefer to listen to the podcast without video? You can do that below!





This month’s MedEvidence is a three-part series on the liver.   In this 12-minute episode Doctors, Michael Koren and Bharat Misra discuss technologies to diagnose dysfunctions of the liver.

You will learn:

  • Technologies in clinical research
  • What a fibroscan is
  • Why your doctor may not be offering you a fibroscan
  • Liver biopsy vs. MRI vs. fibroscan

Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.

Dr. Bharat Misra is the Medical Director of ENCORE Borland Groover Clinical Research and has been a Principal Investigator of numerous clinical trials. He also serves on the board of directors at Memorial Hospital and Jacksonville Center for Clinical Research in Jacksonville, Florida. He completed his residency in internal medicine and fellowship in gastroenterology at the Nassau University Medical Center, State University of New York, and his Bachelor of Medicine and Bachelor of Surgery from Gandhi Medical College in India.


Prefer to listen to the podcast without video? You can do that below!





In this episode, Dr. Michael Koren and Michelle McCormick wrap up their discussion on how clinical trials find the truth as well as truth vs. faith and the conclusion of lady tasting tea. Could she actually tell whether the milk or tea was put in first?

Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.


Prefer to listen to the podcast without video? You can do that below!





In this episode, Dr. Michael Koren and Michelle McCormick walk through the history of Clinical Trials. From Biblical stories of Daniel through the smallpox pandemic to our present COVID pandemic. How far have we come and where do we go from here?

Some of what you will learn:

  • History of Clinical Research
    • Daniel and King Nebuchadnezzar
    • Newgate Prison
    • Cotton Mather & Onesimus
  • Current Vaccine Trials
    • Chickenpox
    • Shingles
    • Covid
    • Flu
    • RSV
  • Future of COVID

Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.


Prefer to listen to the podcast without video? You can do that below!





In this second episode, Dr. Michael Koren, New York Central High School alumni, and Michelle McCormick take us back to high school minus having that awkward conversation about asking your date to prom.  Listen to find out what your high school classes have to do with clinical trials.

Some of what you will learn:

  • What makes a good hypothesis
  • Statistical concepts
  • Statistical methods involved in carrying out a study
  • The vocabulary of clinical research
  • History of clinical research
    • Newgate Prison
    • Daniel and King Nebuchadnezzar
    • Pepsi vs. Coke

Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.


Prefer to listen to the podcast without video? You can do that below!





In a four-part series on What are Clinical Trials & Why are they important, in this first episode Dr. Michael Koren and Michelle McCormick talk about The Science of Clinical Trials, What makes a good Clinical Trial, good?

What do these things have in common?

  • R.A. Fisher
  • Lady Tasting Tea
  • Truth vs Faith
  • Experiments
  • Clinical Trials

Dr. Michael Koren, is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals. Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital / Memorial Sloan-Kettering Cancer Center/ Cornell Medical Center.


Prefer to listen to the podcast without video? You can do that below!





In the final episode of Kicking the Nicotine Habit, It’s a Brain Thing. The MedEvidence! doctors roll out the clinical trials on Cytisinicline, an approved therapy in central and Eastern West Europe for the past 20 years.

This month Dr. Michael Koren and Michelle McCormick talk with Dr. Mitchell Rothstein, a clinical Pulmonary and Sleep Medicine physician for 30 years in the Jacksonville, Florida area.  Dr. Rothstein is the Medical Director of the Phase 1 unit at Jacksonville Center for Clinical Research.

Inside this episode:

  • Cytisinicline
  • Alpha4beta2 Nicotine Receptor
  • Clinical Trials to help quit smoking

Prefer to listen to the podcast without video? You can do that below!





Part 3 in a 4 part series on Kicking the Nicotine Habit, It’s a Brain Thing. The MedEvidence doctors continue their discussion on smoking while diving into nicotine replacement therapies.

This month Dr. Michael Koren and Michelle McCormick talk with Dr. Mitchell Rothstein, a clinical Pulmonary and Sleep Medicine physician for 30 years in the Jacksonville, Florida area.  Dr. Rothstein is the Medical Director of the Phase 1 unit at Jacksonville Center for Clinical Research.

Inside this episode:

  • Nicotine Replacement Therapies
  • Quit smoking medications
  • E-cigarettes & Vaping
  • IQOS – heated tobacco products

Prefer to listen to the podcast without video? You can do that below!





Part 2 in a 4 part series on Kicking the Nicotine Habit, It’s a Brain Thing. Today the doctors dive into the behavioral habits of smoking and give you 5 strategies you can start NOW.

This month Dr. Michael Koren and Michelle McCormick talk with Dr. Mitchell Rothstein, a clinical Pulmonary and Sleep Medicine physician for 30 years in the Jacksonville, Florida area.  Dr. Rothstein is the Medical Director of the Phase 1 unit at Jacksonville Center for Clinical Research.

Inside this episode:

  • Do you want to stop smoking?
  • How do you get to that point?
  • Behavioral Modification strategies
  • 5 Things you can do today to stop smoking

Prefer to listen to the podcast without video? You can do that below!





Part 1 in a 4 part series on Kicking the Nicotine Habit, It’s a Brain Thing.

This month Dr. Michael Koren and Michelle McCormick talk with Dr. Mitchell Rothstein, a clinical Pulmonary and Sleep Medicine physician for 30 years in the Jacksonville, Florida area.  Dr. Rothstein is the Medical Director of the Phase 1 unit at Jacksonville Center for Clinical Research.

Inside this episode:

  • What makes smoking harmful?
  • What makes smoking so addictive?
  • Preventable form of Cardiovascular factors

Prefer to listen to the podcast without video? You can do that below!





Clinical Trials Day is celebrated around the world in May to recognize the day that James Lind started what is often considered the first clinical trial aboard a ship on May 20, 1747.

Here’s the story…

Also included in this month’s MedEvidence! Radio

  • Why we do Clinical Trials
  • Phases of Clinical Trials
  • Why you may want to participate in clinical trials

MedEvidence! Radio is a monthly live broadcast from WSOS 103.9 FM / 1170 AM with Kevin Geddings from St. Augustine, Florida. Dr. Michael Koren is a practicing cardiologist and CEO at ENCORE Research Group. He has been the principal investigator of 2000+ clinical trials while being published in the most prestigious medical journals.  Dr. Koren received his medical degree cum laude at Harvard Medical School and completed his residency in internal medicine with a fellowship in cardiology at New York Hospital/Memorial Sloan-Kettering Cancer Center/Cornell Medical Center.  On a personal note, Dr. Koren has a life-long interest in history, technology, Public Health, and music. He has written two musical plays.


Listen to the full episode here:




This month’s MedEvidence guest, Dr. Steven Toenjes, MD, a board-certified neurologist, former staff neurologist in the U.S. Navy, and an award-winning director of neurology residents at the Uniformed Services University of Health Sciences and decorated Navy veteran, joins Dr. Michael Koren and Michelle McCormick to discuss the future of Alzheimer’s research and what your gut has to do with Alzheimer’s.


Prefer to listen to the podcast without video? You can do that below!





What are all the hullabaloos about Aduhelm, the first new Alzheimer’s drug approval since 2003? This month’s MedEvidence guest, Dr. Steven Toenjes, MD, a board-certified neurologist, former staff neurologist in the U.S. Navy, and an award-winning director of neurology residents at the Uniformed Services University of Health Sciences and decorated Navy veteran joins Dr. Michael Koren and Michelle McCormick to discuss the first new Alzheimer’s drug approval since 2003 and the controversy over FDA’s approval of Biogen’s Aducanumab (Aduhelm).


Prefer to listen to the podcast without video? You can do that below!





In Part 2: Is it Alzheimer’s or Something Else? Drs. Toenjes and Koren begin by answering the popular question, “When do you know something is wrong? Followed by explaining amyloid proteins, DNA structure, Alzheimer’s therapy, and the research behind it.

Dr. Steven Toenjes, MD, a board-certified neurologist, former staff neurologist in the U.S. Navy, and an award-winning director of neurology residents at the Uniformed Services University of Health Sciences and decorated Navy veteran, joins Dr. Michael Koren and Michelle McCormick to discuss Alzheimer’s disease in a four-part series.


Prefer to listen to the podcast without video? You can do that below!





This month’s MedEvidence guest, Dr. Steven Toenjes, MD, a board-certified neurologist, former staff neurologist in the U.S. Navy, and an award-winning director of neurology residents at the Uniformed Services University of Health Sciences and decorated Navy veteran joins Dr. Michael Koren and Michelle McCormick to discuss Alzheimer’s disease in a four-part series.

With over six million Americans believed to have Alzheimer’s disease and the sixth leading cause of death in the United States, MedEvidence breaks down Dementia vs. Alzheimer’s, including diagnosis and treatments.


Prefer to listen to the podcast without video? You can do that below!





In this final episode on longevity, Dr. Michael Koren, Dr. Victoria Helow, and Michelle McCormick talk about medical research and apply its wisdom to maximize a healthy lifestyle. Topics discussed:

  • Aspirin: Doses, Purposes & Populations
  • Types of anti-inflammatories
  • Importance of Cholesterol numbers
  • RNA Technology
  • Viruses
  • Vaccines
  • Hugging vs. Handshake
  • Becoming Part of Advancing Science

Related articles:


Prefer to listen to the podcast without video? You can do that below!





What is the formula to living longer? In this third episode in our four-part series Dr. Michael Koren, Dr. Victoria Helow, and Michelle McCormick apply medical research to fish, nuts, sex, sunscreen, and more.

Related articles:


Prefer to listen to the podcast without video? You can do that below!





Can medical research help us live longer? In this four-part series Dr. Michael Koren, Dr. Victoria Helow, and Michelle McCormick discuss the relevant medical evidence and apply its wisdom to discover the secrets to longevity.

Related articles:


Prefer to listen to the podcast without video? You can do that below!





Can medical research help us live longer? In this four-part series Dr. Michael Koren, Dr. Victoria Helow, and Michelle McCormick discuss the relevant medical evidence and apply its wisdom to discover the secrets to longevity.

Related articles:


Prefer to listen to the podcast without video? You can do that below!



Encore logo

As a proven clinical research organization, we take every precaution to ensure the safety of and maximize the value for our research volunteers. Qualified doctors, nurses and study coordinators on staff provide support and care throughout the research trial. Participation is always voluntary. We appreciate the time and effort that research volunteers bring to this important process.

Copyright 2023 ENCORE Research Group